NICOTINE TRANSDERMAL SYSTEM, STEP 1, STEP 2, STEP 3

Drug Labeling and Warnings

Drug Details [pdf]

NICOTINE TRANSDERMAL SYSTEM STEP 1- nicotine patch, extended release 
NICOTINE TRANSDERMAL SYSTEM STEP 2- nicotine patch, extended release 
NICOTINE TRANSDERMAL SYSTEM STEP 3- nicotine patch, extended release 
Preferred Plus (Kinray)

----------

NICOTINE TRANSDERMAL SYSTEM, STEP 1, STEP 2, STEP 3

 Drug Facts

Active ingredient (in each patch)

Active ingredient Step 1
Nicotine, 21mg delivered over 24 hours

Active ingredient Step 2
Nicotine, 14 mg delivered over 24 hours

Active ingredient Step 3
Nicotine, 7 mg delivered over 24 hours

Purpose

Stop smoking aid

Use

reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

Warnings

If you are pregnant or breast-feeding, only use this medicine on the advice of your health care provider. Smoking can seriously harm your child. Try to stop smoking without using any nicotine replacement medicine. This medicine is believed to be safer than smoking. However, the risks to your child from this medicine are not fully known.

Do not use

  • if you continue to smoke, chew tobacco, use snuff, use nicotine gum, or use nicotine patch or other nicotine-containing products

Ask a doctor before use if you have

  • heart disease, recent heart attack, or irregular heartbeat. Nicotine can increase your heart rate.
  • high blood pressure not controlled with medication. Nicotine can increase your blood pressure.
  • an allergy to adhesive tape or skin problems because you are more likely to get rashes

Ask a doctor or a pharmacist before use if you are

  • using a non-nicotine stop smoking drug
  • taking a prescription medicine for depression or asthma. Your prescription dose may need to be adjusted.

When using this product

  • do not smoke even when not wearing the patch. The nicotine in your skin will still be entering your bloodstream for several hours after you take off the patch.
  • if you have vivid dreams or other sleep disturbances remove this patch at bedtime

Stop use and ask a doctor if

  • skin redness caused by the patch does not go away after four days, or  your skin swells, or you get a rash
  • irregular heartbeat or palpitations occur
  • you get symptoms of nicotine overdose, such as nausea, vomiting, dizziness, weakness and rapid heartbeat

Keep out of reach of children and pets.

Used patches have enough nicotine to poison children and pets. If swallowed, get medical help or contact a Poison Control Center right away. Save pouch to use for patch disposal. Dispose of used patch by folding sticky ends together and putting in pouch.

Directions

  • if you are under 18 years of age, ask a doctor before use
  • before using this product, read the enclosed self-help guide for complete directions and other information
  • stop smoking completely when you begin using the patch
  • if you smoke more than 10 cigarettes per day, use the following schedule:
nicotine step 1-table
  • if you smoke 10 or less cigarettes per day, start with Step 2 for 6 weeks, then Step 3 for 2 weeks and then stop
  • apply one new patch every 24 hours on skin that is dry, clean and hairless
  • remove backing from patch and immediately press onto skin. Hold for 10 seconds.
  • wash hands after applying or removing patch. Save pouch to use for patch disposal. Dispose of used patch by folding sticky ends together and putting in pouch.
  • the used patch should be removed and a new one applied to a different skin site at the same time each day
  • if you have vivid dreams, you may remove the patch at bedtime and apply a new one in the morning
  • do not wear more than one patch at a time
  • do not cut patch in half or into smaller pieces
  • do not leave patch on for more than 24 hours because it may irritate your skin and loses strength after 24 hours
  • stop using the patch at the end of 8 weeks. If you still feel the need to use the patch talk to your doctor.

Other information

store at 20°-25°C (68°-77°F)

Inactive ingredients

acrylate adhesive, polyester, silicone adhesive

Comments or questions?

Call 1-877-440-7867

Principal Display Panel

NDC: 61715-085-14

COMPARE TO THE ACTIVE INGREDIENT IN HABITROL®*

Nicotine Transdermal System, Step 1
21 mg Delivered Over 24 Hours
STOP SMOKING AID

Preferred Plus Pharmacy®

Distributed by: Kinray LLC.,
152-35 10th Ave.,
Whitestone, NY 11357

21 mg
14 Pactches

preferred-nicotine step1

Principal Display Panel

NDC: 61715-086-14

COMPARE TO THE ACTIVE INGREDIENT IN HABITROL®*

Nicotine Transdermal System, Step 2
14 mg Delivered Over 24 Hours
STOP SMOKING AID

Preferred Plus Pharmacy®

Distributed by: Kinray LLC.,
152-35 10th Ave.,
Whitestone, NY 11357

14 mg
14 Pactches

nicotine step2

Principal Display Panel

NDC: 61715-087-14

COMPARE TO THE ACTIVE INGREDIENT IN HABITROL®*

Nicotine Transdermal System, Step 3
7 mg Delivered Over 24 Hours
STOP SMOKING AID

Preferred Plus Pharmacy®

Distributed by: Kinray LLC.,
152-35 10th Ave.,
Whitestone, NY 11357

7 mg
14 Pactches

nicotine step3
NICOTINE TRANSDERMAL SYSTEM  STEP 1
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 61715-085
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE21 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
HEPTANE (UNII: 456148SDMJ)  
XYLENE (UNII: D856J1047R)  
ETHYL ACETATE (UNII: 76845O8NMZ)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
TOLUENE (UNII: 3FPU23BG52)  
ETHYLBENZENE (UNII: L5I45M5G0O)  
VINYL ACETATE (UNII: L9MK238N77)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 61715-085-1414 in 1 CARTON10/01/199902/29/2016
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/01/199902/29/2016
NICOTINE TRANSDERMAL SYSTEM  STEP 2
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 61715-086
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE14 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
HEPTANE (UNII: 456148SDMJ)  
XYLENE (UNII: D856J1047R)  
ETHYL ACETATE (UNII: 76845O8NMZ)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
TOLUENE (UNII: 3FPU23BG52)  
ETHYLBENZENE (UNII: L5I45M5G0O)  
VINYL ACETATE (UNII: L9MK238N77)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 61715-086-1414 in 1 CARTON10/01/199902/29/2016
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/01/199902/29/2016
NICOTINE TRANSDERMAL SYSTEM  STEP 3
nicotine patch, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 61715-087
Route of AdministrationTRANSDERMAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NICOTINE (UNII: 6M3C89ZY6R) (NICOTINE - UNII:6M3C89ZY6R) NICOTINE7 mg  in 24 h
Inactive Ingredients
Ingredient NameStrength
HEPTANE (UNII: 456148SDMJ)  
XYLENE (UNII: D856J1047R)  
ETHYL ACETATE (UNII: 76845O8NMZ)  
ISOPROPYL ALCOHOL (UNII: ND2M416302)  
TOLUENE (UNII: 3FPU23BG52)  
ETHYLBENZENE (UNII: L5I45M5G0O)  
VINYL ACETATE (UNII: L9MK238N77)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 61715-087-1414 in 1 CARTON10/01/199912/31/2015
11 in 1 POUCH
124 h in 1 PATCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA07461210/01/199912/31/2015
Labeler - Preferred Plus (Kinray) (012574513)

Revised: 6/2019